Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

The inhibitory receptor CTLA4 has a key role in peripheral tolerance of T cells for both normal and tumor-associated antigens. Murine experiments suggested that blockade of CTLA4 might have antitumor activity and a clinical experience with the blocking antibody ipilimumab in patients with metastatic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang, James C., Hughes, Marybeth, Kammula, Udai, Royal, Richard, Sherry, Richard M., Topalian, Suzanne L., Suri, Kimberly B., Levy, Catherine, Allen, Tamika, Mavroukakis, Sharon, Lowy, Israel, White, Donald E., Rosenberg, Steven A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134980/
https://ncbi.nlm.nih.gov/pubmed/18049334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318156e47e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares